Vaccines in sickle cell disease

被引:0
作者
Diamantopoulos, P. [1 ]
Giakoumi, X. [1 ]
Andreopoulos, A. [1 ]
机构
[1] Natl & Capodistrian Univ Athens, Sch Med, Laiko Gen Hosp, Dept Internal Med 1st, Athens, Greece
来源
ARCHIVES OF HELLENIC MEDICINE | 2009年 / 26卷 / 04期
关键词
Active immunization; Sickle cell disease; Vaccines;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients suffering from sickle cell disease are prone to bacterial infections, due to anatomic or functional asplenia. Active immunization against several pathogens is essential in the management of such patients. Children, adolescents and adults with sickle cell disease should be vaccinated with all the vaccines included in the National Immunization Program. Moreover, they should also be vaccinated against polysaccharide encapsulated bacteria (N. meningitidis, H. influenza type b, and Streptococcus pneumoniae) because of their impaired immunity against those organisms. These patients are considered a high risk group for acquiring viral blood borne infections via blood transfusion, and should be vaccinated against hepatitis B virus, and they should be vaccinated each year against the influenza virus due to the risk of developing severe pulmonary bacterial infections during the course of an influenza virus infection. This article comprises updated information about active immunization in patients with sickle cell disease, including indications, contraindications, adverse reactions, effectiveness and a vaccination timetable for this particular group of patients.
引用
收藏
页码:496 / 502
页数:7
相关论文
共 26 条
  • [1] Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life
    Adamkiewicz, Thomas V.
    Silk, Benjamin J.
    Howgate, James
    Baughman, Wendy
    Strayhorn, Gregory
    Sullivan, Kevin
    Farley, Monica M.
    [J]. PEDIATRICS, 2008, 121 (03) : 562 - 569
  • [2] Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination
    Adamkiewicz, TV
    Sarnaik, S
    Buchanan, GR
    Iyer, RV
    Miller, ST
    Pegelow, CH
    Rogers, ZR
    Vichinsky, E
    Elliott, J
    Facklam, RR
    O'Brien, KL
    Schwartz, B
    Beneden, CAV
    Cannon, MJ
    Eckman, JR
    Keyserling, H
    Sullivan, K
    Wong, WY
    Wang, WC
    [J]. JOURNAL OF PEDIATRICS, 2003, 143 (04) : 438 - 444
  • [3] POLYVALENT PNEUMOCOCCAL-POLYSACCHARIDE IMMUNIZATION OF PATIENTS WITH SICKLE-CELL-ANEMIA AND PATIENTS WITH SPLENECTOMY
    AMMANN, AJ
    ADDIEGO, J
    WARA, DW
    LUBIN, B
    SMITH, WB
    MENTZER, WC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (17) : 897 - 900
  • [4] [Anonymous], 2005, FDA NEWS SEP
  • [5] IMPAIRED IGM ANTIBODY-RESPONSES TO AN INFLUENZA-VIRUS VACCINE IN ADULTS WITH SICKLE-CELL ANEMIA
    BALLESTER, OF
    ABDALLAH, JM
    PRASAD, AS
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1985, 20 (04) : 409 - 412
  • [6] PNEUMOCOCCAL SEPTICEMIA DESPITE PNEUMOCOCCAL VACCINE AND PRESCRIPTION OF PENICILLIN PROPHYLAXIS IN CHILDREN WITH SICKLE-CELL-ANEMIA
    BUCHANAN, GR
    SMITH, SJ
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1986, 140 (05): : 428 - 432
  • [7] DAVIES EG, 2004, COCHRANE DB SYST REV
  • [8] DEMONTALEMBERT M, 1993, ARCH FR PEDIATR, V50, P863
  • [9] GARDNER P, 1993, NEW ENGL J MED, V328, P1252, DOI 10.1056/NEJM199304293281708
  • [10] Ghaffar Faryal, 2005, Expert Opin Drug Saf, V4, P631, DOI 10.1517/14740338.4.4.631